Tilray's Distribution Segment Drives Most Growth in Fiscal 2026
Tilray Brands (NASDAQ: TLRY) reported fiscal year-end results for 2026, revealing that its distribution business was the primary driver of growth. Despite being less visible than its cannabis or beverage segments, this division saw a significant increase with revenue growing by 21% to over $327 million. The company's total net revenue reached $915.5 million for fiscal year ending May 31, reflecting an overall 11% growth compared to the previous year. While all segments contributed positively, only distribution achieved double-digit expansion. CEO Irwin Simon highlighted Europe as a key market where Tilray has established one of the most comprehensive medical cannabis and pharmaceutical platforms. Despite recent stock price gains following these results, Tilray's shares remain nearly 50% below their level at the start of the year. The company continues to face profitability challenges with an operating loss of $63 million during fiscal 2026.